Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity (PROMETEOII)

July 10, 2023 updated by: Universitat Jaume I

Treatment of Depression: Efficacy and Efficiency of Two Self-administered Online Intervention Protocols Based on Behavioral Activation and Physical Activity

To compare the clinical and cost-effectiveness of Behavioral Activation (BA) and Physical Activity (PA) for adults with major depressive disorder (MDD) or adjustment disorder with depressive symptomatology with a wait list control group (WL) in Spanish population.

Study Overview

Detailed Description

Research shows that in 2030 (Mathers and Loncar, 2006) depression will become one of the three leading causes of disability. Depression is a common mental disorder with a negative impact on mental well-being, quality of life, and social and work-related functioning both in the short and longer term.

Additionally, depression is associated with increased morbidity, mortality, health care utilization and health care costs. On a population level, depression is one of the most costly diseases. The economic costs of depression were estimated at €136.3 billion (EU25) in 2010 in the EU and are still rising. European health care systems face the challenge of improving access to cost-effective treatments while simultaneously working to sustain budgetary stability in times of economic austerity.

Internet-based depression treatment appears a very promising alternative to current routine depression treatment strategies. Meta-analyses have demonstrated the clinical effectiveness and potential cost-effectiveness of Internet-based treatment for depression in controlled research setting. Internet-based treatment thus has the potential to keep depression treatment affordable, as it enables mental health care providers to reach out to large populations needing depression treatment at a better cost-effectiveness, but with similar levels of clinical efficacy and quality of care.

In Spain the trial will be carried out in a community sample, comparing the clinical and cost-effectiveness of BA or PA with WL for adults with major depressive disorder (MDD) and adjustment disorder with depressive symptomatology. Respondents will be followed until 6 months after baseline (measures will be taken at BL, 3 months, and 6 months).

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Cristina Botella, PhD
  • Phone Number: 7639 +34 964 38 76 39
  • Email: botella@uji.es

Study Contact Backup

Study Locations

      • Castelló de la Plana, Spain, 12071
        • University Jaume I

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being 18 years of age or older
  • Meet DSM-IV diagnostic criteria for MDD and adjustment disorder confirmed by MINI International Neuropsychiatric Interview version 5.0 and SCID I
  • A score of 5 or higher on the PHQ-9 screening questionnaire.

Exclusion Criteria:

  • Current high risk for suicide according to the MINI Interview section C
  • Serious psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive compulsive disorder, as established at the MINI interview
  • Currently receiving psychological treatment for depression in primary or specialised mental health care
  • Being unable to comprehend the spoken and written language (Spanish)
  • Not having access to a PC and fast Internet connection (i.e. broadband or comparable).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Activation
BA treatment for depression is a simple, cost-effective method. There is evidence that the behavioral component may be the active mechanism of change in cognitive-behavioral treatments of clinical depression. One of the main objectives of the treatment is to systematically increase exposure to positive activities, and thereby improve affect and corresponding cognitions. Treatment will be delivered through an Internet based treatment platform with mobile phone components (either integrated in the treatment platform or as a separate system). The core components are: 1) psycho-education, 2) identifying important values and significant activities, 3) activity structuring and scheduling, 4) relapse prevention. These will be delivered over 4 modules. There will be a minimal therapist support.
Behavioral Activation intervention promotes the involvement in meaningful activities close to personal values.
No Intervention: Waiting list control group
In the waiting list control group (WL), subjects will receive no treatment during 8 weeks. We will not interfere but we will monitor carefully through self-report. Then participants will be randomised to the two treatment groups.
Experimental: Physical Activity
There is evidence to suggest that the addition of cognitive behavioral therapies, specifically exercise, can improve treatment outcomes for many patients. Exercise is a behavioral intervention that has shown great promise in alleviating symptoms of depression. The treatment will be delivered through an Internet based treatment platform with mobile phone components (either integrated in the treatment platform or as a separate system). The core components of the PA treatment are: 1) psychoeducation: understand the mental health benefits of physical activity, 2) learn about the types and amounts of physical activity recommended, 3) motivation to perform and maintain physical activities, 4) relapse prevention. These will be delivered over 4 modules. There will be a minimal therapist support.
Physical Activity intervention promotes the gradual increase of the frequency and intensity of PA levels, with special attention to motivational strategies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Patient Health Questionnaire-9
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Beck Depression Inventory
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in the EQ-5D-5L (EuroQol)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Quality of Life (QLI)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Positive and Negative Affect Scale (PANAS)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Happiness Scale (Fordyce)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Satisfaction with Life Scale (SWLS, Diener)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Ryff Scale of Psychological Wellbeing
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Behavioral Activation for Depression Scale - Short Form (BADS-SF)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in the Environmental Reward Observation Scale (EROS)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months
Change in Beck Depression Inventory (BDI-II)
Time Frame: Change from baseline to 2 months, 5 months, and 8 months
Change from baseline to 2 months, 5 months, and 8 months

Other Outcome Measures

Outcome Measure
Time Frame
Eysenck Personality Questionnaire-Revised Short Form (Neuroticism subscale)
Time Frame: Baseline
Baseline
Credibility and expectancy questionnaire (CEQ)
Time Frame: 2 weeks
2 weeks
Self concordance motivation (SCM)
Time Frame: 2 weeks
2 weeks
Working Alliance Inventory (WAI-SF)
Time Frame: 3 weeks
3 weeks
System usability scale (SUS)
Time Frame: 2 months
2 months
Change in preferences for treatment scale (self-applied vs face to face)
Time Frame: Change from baseline to 2 months
Change from baseline to 2 months
Satisfaction with the treatment
Time Frame: 2 months
2 months
Change in the MINI International Neuropsychiatric Interview (M.I.N.I) version 5.0
Time Frame: Change from baseline to 2 months
Change from baseline to 2 months
Change in Structured Clinical Interview (SCID-I) for Adjustment Disorders
Time Frame: Change from baseline to 2 months
Change from baseline to 2 months
Attitudes towards Psychological Online Interventions Questionnaire (APOI)
Time Frame: Baseline
Baseline
Semi-structured interview about users´ intervention experience
Time Frame: 2 months
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cristina Botella, PhD, Universitat Jaume I;CIBERObn ISC III, Spain
  • Principal Investigator: Rosa Baños, PhD, Universitat de Valencia; CIBERObn ISC III, Spain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

February 1, 2023

Study Registration Dates

First Submitted

February 16, 2015

First Submitted That Met QC Criteria

February 16, 2015

First Posted (Estimated)

February 23, 2015

Study Record Updates

Last Update Posted (Actual)

July 11, 2023

Last Update Submitted That Met QC Criteria

July 10, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Behavioral Activation

3
Subscribe